0

CP466722

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP1080622861
CAS1080622-86-1
MDL NumberMFCD17392566
Molecular Weight349.35
InChI KeyILBRKJBKDGCSCB-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 0.5 mg/mL, clear (warmed)
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
Size5MG, 25MG
Storage Conditions2-8°C
1

Ataxia-telangiectasia Mutated and the Mre11-Rad50-NBS1 Complex: Promising Targets for Radiosensitization

Shinji Kuroda, Yasuo Urata, Toshiyoshi Fujiwara

Acta Med Okayama. 2012;66(2):83-92.

PMID: 22525466

1

ATM in DNA Repair in Cancer

Mei Hua Jin, Do-Youn Oh

Pharmacol Ther. 2019 Nov;203:107391.

PMID: 31299316

1

Chemoproteomic Selectivity Profiling of PIKK and PI3K Kinase Inhibitors

Maria Reinecke, Benjamin Ruprecht, Sandra Poser, Svenja Wiechmann, Mathias Wilhelm, Stephanie Heinzlmeir, Bernhard Kuster, Guillaume Médard

ACS Chem Biol. 2019 Apr 19;14(4):655-664.

PMID: 30901187

1

Inhibition of ATM Reverses EMT and Decreases Metastatic Potential of Cisplatin-Resistant Lung Cancer Cells Through JAK/STAT3/PD-L1 Pathway

Mingjing Shen, Zhonghua Xu, Weihua Xu, Kanqiu Jiang, Fuquan Zhang, Qifeng Ding, Zhonghen Xu, Yongbing Chen

J Exp Clin Cancer Res. 2019 Apr 8;38(1):149.

PMID: 30961670

1

Transient Inhibition of ATM Kinase Is Sufficient to Enhance Cellular Sensitivity to Ionizing Radiation

Michael D Rainey, Maura E Charlton, Robert V Stanton, Michael B Kastan

Cancer Res. 2008 Sep 15;68(18):7466-74.

PMID: 18794134

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode